Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimal Islet Transplantation in New-onset Type 1 Diabetes
NCT02505893Phase 2Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Apr 2015
- Primary completion
- May 2018
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of donislecel in type 1 diabetes mellitus (T1D), sponsored by IRCCS Ospedale San Raffaele. Started Apr 2015; status: completed.
02
Drugs
donislecel
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02505893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02505893.